The effect of mepolizumab, an anti-IL-5 monoclonal antibody, on eosinophilic otitis media associated with severe asthma

• Yuki Maruyama,
• Isao Suzaki,
• Kojiro Hirano,
• Hitome Kobayashi

Affiliations

Yuki Maruyama

Department of Otorhinolaryngology, School of Medicine, Showa University, Tokyo, Japan

Isao Suzaki

Department of Otorhinolaryngology, School of Medicine, Showa University, Tokyo, Japan

Kojiro Hirano

Department of Otorhinolaryngology, School of Medicine, Showa University, Tokyo, Japan

Hitome Kobayashi

Department of Otorhinolaryngology, School of Medicine, Showa University, Tokyo, Japan